scispace - formally typeset
A

Azar Baradaran

Researcher at Isfahan University of Medical Sciences

Publications -  172
Citations -  4345

Azar Baradaran is an academic researcher from Isfahan University of Medical Sciences. The author has contributed to research in topics: Hemodialysis & Creatinine. The author has an hindex of 33, co-authored 163 publications receiving 3824 citations. Previous affiliations of Azar Baradaran include Shahrekord University of Medical Sciences & University of Isfahan.

Papers
More filters
Journal Article

Atherosclerosis: process, indicators, risk factors and new hopes.

TL;DR: The pathogenesis factors involved in Atherosclerosis have recently been cleared and the discovery of these factors has brought about new hopes for better prevention and treatment of atherosclerosis.
Journal Article

New concepts in nutraceuticals as alternative for pharmaceuticals.

TL;DR: In the present review, emphasis has been made to present herbal nutraceuticals effective on hard curative disorders related to oxidative stress including allergy, alzheimer, cardiovascular, cancer, diabetes, eye, immune, inflammatory and Parkinson's diseases as well as obesity.
Journal Article

Oxidative stress and hypertension: Possibility of hypertension therapy with antioxidants.

TL;DR: A list of medicinal plants that have been reported to be effective in hypertension is also presented in this paper, where the main focus is the main effect of antioxidants on hypertension and cardiovascular risk factors, however, antioxidant supplementation has not been shown consistently to be able to improve blood pressure after treatment with single or combination antioxidant therapy in subjects thought to be at high risk of cardiovascular disease.
Journal ArticleDOI

Plants antioxidants: From laboratory to clinic.

TL;DR: Eating whole vegetables, fruits and grains, which all are rich in antioxidants, provides protection against most of oxidative stress induced diseases, however, this does not mean that antioxidants will prevent or fix the problem, especially not when they are taken out of their natural context.
Journal Article

Ameliorative effects of metformin on renal histologic and biochemical alterations of gentamicin-induced renal toxicity in Wistar rats.

TL;DR: Testifies that metformin may prevent or ameliorate GM-induced acute renal failure, and therefore it might be beneficial in patients under treatment with this medicine.